The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Yidu Tech's quick ratio for the quarter that ended in Sep. 2023 was 8.65.
Yidu Tech has a quick ratio of 8.65. It generally indicates good short-term financial strength.
The historical rank and industry rank for Yidu Tech's Quick Ratio or its related term are showing as below:
STU:0EL'
s Quick Ratio Range Over the Past 10 Years
Min: 0.32 Med: 7.43 Max: 12.35
Current: 8.65
During the past 6 years, Yidu Tech's highest Quick Ratio was 12.35. The lowest was 0.32. And the median was 7.43.
STU:0EL's Quick Ratio is ranked better than 95.45% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 1.2
vs STU:0EL: 8.65
Yidu Tech Quick Ratio Historical Data
The historical data trend for Yidu Tech's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Yidu Tech's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yidu Tech's Quick Ratio Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Yidu Tech's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Yidu Tech's Quick Ratio falls into.
Yidu Tech Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Yidu Tech's Quick Ratio for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yidu Tech (STU:0EL) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Yidu Tech Quick Ratio Related Terms
Thank you for viewing the detailed overview of Yidu Tech's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Yidu Tech offers healthcare Big Data. It is an AI cloud-based firm providing solutions and tools to aid in more informed decisions to drive better efficiency in clients' strategies. Its clients are hospitals, pharmaceutical, biotech and medical device firms, research institutions, insurance companies, patients, and regulators. It three business segments are: Big Data platform and solutions, which partners with hospitals and policymakers to drive better efficiency; life sciences solutions, which enables better probability of clinical trial success with less drug development time and cost; and health management solutions, which helps with patient management. The Big Data platform accounted for 33% of revenue, life science solutions 30%, and health management solutions 27%, in fiscal 2022.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:0EL has been successfully added to your 